Screener
AnaptysBio, Inc. ANAB Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $248,469 | $238,196 |
| Receivables from collaborative partners | 25,747 | 33,850 |
| Short-term investments | 37,986 | 73,442 |
| Prepaid expenses and other current assets | 3,907 | 4,762 |
| Total current assets | 316,109 | 350,250 |
| Property and equipment, net | 1,280 | 1,370 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s accounts receivable?
- AnaptysBio, Inc. (ANAB) reported accounts receivable of $25.75M in Q1 2026.
- How has AnaptysBio, Inc.'s accounts receivable changed year-over-year?
- AnaptysBio, Inc.'s accounts receivable increased by 44.0% year-over-year, from $17.88M to $25.75M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about AnaptysBio, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude